Device Trial Radar · NCT04710355
Objective Data on Daily Activity in Patients Treated with SCS: the Intellis Study
Last checked: Nov 20, 2026Latest source record: Jan 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
50
Actual
Start
Aug 1, 2020
Primary completion
Jul 31, 2024
Study completion Jul 31, 2024
Sponsor
- Lead sponsor
- Sahlgrenska University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 14, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In spinal cord stimulation (SCS), most outcome data are based on patient questionnaires. The lack of tools for objective evaluation of the effects of SCS on chronic pain has posed a barrier for providing solid proof of the therapy. Currently, however, SCS-devices with an accelerator included are available on the market. The position orientation data provided by the neurostimulator therefore gives new possibilities for objective measurement of gross activity in daily life.
Conditions
- Failed Back Surgery Syndrome
Interventions
Spinal cord stimulationDevice
Adhesion of Intellis spinal cord stimulator to the skin of the abdomen for 4 weeks for baseline recording of activity level prior to trial with spinal cord stimulation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Position reporting: Intellis SnapShot ReportingTime frame: Change from baseline Intellis SnapShot Reporting at 12 months
Locations
7 sites in 4 countries. Site status is shown where the registry gives one.
AZ Delta Hospital
Roeselare, Belgium
Aalborg University Hospital
Aalborg, Denmark
Rijnstate Hospital
Arnhem, Netherlands
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.